Dominic Borie
Fortuna: 803 880 $ al 31/08/2026
Fortuna: 803 880 $ al 31/08/2026
Dr. Dominic Borie is a Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. Dr. Borie was previously employed as a President-Research & Development by Kyverna Therapeutics, Inc., a VP, Head-External Research & Development by Horizon Therapeutics Ltd. (Ireland), a Senior Medical Director by Genentech, Inc., a Medical Director by Amgen, Inc., a Director-Transplantation Research by Roche Pharmaceuticals, Inc., a Director-Transplantation Immunology Laboratory by Stanford University, and an Executive Director by Allogene Therapeutics, Inc. He received his undergraduate degree from North Carolina State University, a doctorate degree from Universite Paris Est Creteil Val De Marne, a doctorate degree from Universite Paris Cite and a doctorate degree from The University of Texas at Austin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,43 % | 13/07/2026 | 31.500 ( 0,43 % ) | 803 880 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CUE BIOPHARMA, INC. | Director Técnico/Científico/I+D | 13/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Director Ejecutivo | 13/10/2022 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/01/2020 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Director Técnico/Científico/I+D | 01/02/2016 |
| AMGEN INC. | Director Técnico/Científico/I+D | 01/08/2013 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01/12/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Est Creteil Val De Marne
Universite Paris Est Creteil Val De Marne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.